Earnings Call · Q1 FY2023·2023-05-13

Q1 23EPS -5.00%·Rev n/aQ4 22EPS +1.72%·Rev n/aQ3 22EPS -7.55%·Rev n/aQ2 22EPS -10.00%·Rev n/a⚠ consensus missing

Xenon Pharmaceuticals Inc. XENE

Sherry Aulin — Chief Financial Officer

Ian Mortimer — President and Chief Executive Officer

Dr. Chris Kenney — Chief Medical Officer

−5.5%1d on move date−6.0% vs SPY3d−7.8%5d−5.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XENE calls or request research access.

More XENE calls Browse calls Request research access